Cited by 979Smoking Behavior and CessationNicotinic Acetylcholine Receptors StudySubstance Abuse Treatment and Outcomes

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics

Open access

Benowitz, Neal L.·2009·Annual Review of Pharmacology and Toxicology

DOI 10.1146/annurev.pharmtox.48.113006.094742PMC PMC2946180

Open this paper in CoChat — free account

Abstract

Nicotine sustains tobacco addiction, a major cause of disability and premature death. Nicotine binds to nicotinic cholinergic receptors, facilitating neurotransmitter release and thereby mediating the complex actions of nicotine in tobacco users. Dopamine, glutamate, and gamma aminobutyric acid release are particularly important in the development of nicotine dependence, and corticotropin-releasing factor appears to contribute to nicotine withdrawal. Nicotine dependence is highly heritable. Genetic studies indicate roles for nicotinic receptor subtypes, as well as genes involved in neuroplasticity and learning, in development of dependence. Nicotine is primarily metabolized by CYP 2A6, and variability in rate of metabolism contributes to vulnerability to tobacco dependence, response to smoking cessation treatment, and lung cancer risk. Tobacco addiction is much more common in persons with mental illness and substance abuse disorders, representing a high proportion of current smokers. Pharmacotherapeutic approaches to tobacco addiction include nicotine replacement, bupropion, and varenicline, the latter a selective nicotine receptor partial agonist.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1146/annurev.pharmtox.48.113006.094742

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
The Health Consequences of Smoking: A Report of the Surgeon General
Office on Smoking (2004) · Cited by 2,414
Signs and Symptoms of Tobacco Withdrawal
Hughes, J. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800030107013 · Cited by 1,669
Metabolism and Disposition Kinetics of Nicotine
Hukkanen, J., Jacob, P., & Benowitz, N. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.3 · Cited by 1,583
Self-citation
A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update
(2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.04.009 · Cited by 1,410
Synaptic plasticity and addiction
Kauer, J. A., & Malenka, R. C. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2234 · Cited by 1,397
Is there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388
Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
Gonzales, D. (2006) · JAMA · doi:10.1001/jama.296.1.47 · Cited by 1,361
Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states.
(2006) · Europe PMC (PubMed Central) · Cited by 1,299
Damage to the insula disrupts addiction to cigarette smoking
Naqvi, N. H., Rudrauf, D., Damasio, H., & Bechara, A. (2007) · Science · doi:10.1126/science.1135926 · Cited by 1,245
Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial
Møller, A. M., Villebro, N., Pedersen, T., & Tønnesen, H. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07369-5 · Cited by 1,109
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs
Saccone, S. F., Hinrichs, A. L., Saccone, N. L., Chase, G. A., Konvicka, K., Madden, P. A. F., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl438 · Cited by 850 · cited 1×
“Bierut, Saccone, and coworkers examined a phenotype that is thought to reflect a vulnerability to becoming dependent on nicotine (48, 49).”
Background
Smoking and Major Depression: A Causal Analysis
Kendler, K. S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130038007 · Cited by 792
Ethnic and Racial Differences in the Smoking-Related Risk of Lung Cancer
Haiman, C. A., Stram, D. O., Wilkens, L. R., Pike, M. C., Kolonel, L. N., Henderson, B. E., & Marchand, L. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa033250 · Cited by 780
Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization
Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C., Whiteaker, P., Marks, M. J., Collins, A. C., & Lester, H. A. (2004) · Science · doi:10.1126/science.1099420 · Cited by 686
Dramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674
Effect of Maintenance Therapy With Varenicline on Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
Tonstad, S. (2006) · JAMA · doi:10.1001/jama.296.1.64 · Cited by 660
Nicotine Metabolism and Intake in Black and White Smokers
Pérez-Stable, E. J. (1998) · JAMA · doi:10.1001/jama.280.2.152 · Cited by 631
Novel genes identified in a high-density genome wide association study for nicotine dependence
Bierut, L. J., Madden, P. A. F., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O. F., Swan, G. E., Rutter, J., Bertelsen, S., Fox, L., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl441 · Cited by 622
Molecular and cellular aspects of nicotine abuse
Dani, J. A., & Heinemann, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80112-9 · Cited by 605
Co‐Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders
Kalman, D., Morissette, S. B., & George, T. P. (2005) · The American Journal on Addictions · doi:10.1080/10550490590924728 · Cited by 594
Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort
Hurt, R. D. (1996) · JAMA · doi:10.1001/jama.275.14.1097 · Cited by 574
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J.-P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., et al. (2005) · Nature · doi:10.1038/nature03694 · Cited by 566 · cited 1×
“Reinserting the β2 subunit gene into the ventral tegmental area of a β2 knockout mouse restores behavioral responses to nicotine (5).”
Background
Cardiovascular Toxicity of Nicotine: Implications for Nicotine Replacement Therapy 11All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California San Francisco.
Benowitz, N. L., & Gourlay, S. G. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00079-x · Cited by 529
Self-citation
Bupropion is a nicotinic antagonist
Slemmer, J. E., Martin, B. R., & Damaj, M. I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38905-0 · Cited by 509
The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease
Joseph, A. M., Norman, S. M., Ferry, L. H., Prochazka, A. V., Westman, E. C., Steele, B. G., Sherman, S. E., Cleveland, M., Antonuccio, D. O., Hartman, N., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612123352402 · Cited by 492
Female sex and oral contraceptive use accelerate nicotine metabolism
BENOWITZ, N., LESSOVSCHLAGGAR, C., SWAN, G., & JACOBIII, P. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.01.008 · Cited by 486
Self-citation
Familial Transmission of Substance Dependence: Alcohol, Marijuana, Cocaine, and Habitual Smoking
Bierut, L. J., Dinwiddie, S. H., Begleiter, H., Crowe, R., HESSELBROCK, V. M., Nürnberger, J. I., Bernice Porjesz, A., Schuckit, M. A., & Reich, T. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.11.982 · Cited by 484
Cellular and synaptic mechanisms of nicotine addiction
Mansvelder, H. D., & McGehee, D. S. (2002) · Journal of Neurobiology · doi:10.1002/neu.10148 · Cited by 450
Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity*1
DEMPSEY, D. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.02.011 · Cited by 430
Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment
Benowitz, N. L. (2003) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(03)00087-2 · Cited by 429
Self-citation
Cellular mechanisms of nicotine addiction
Dani, J. A., & De Biasi, M. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00652-9 · Cited by 408
Higher levels of nicotine in arterial than in venous blood after cigarette smoking
Henningfield, J. E. (1993) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(93)90030-t · Cited by 370
Cigarette Smoking Saturates Brain α4β2 Nicotinic Acetylcholine Receptors
Brody, A. L., Mandelkern, M. A., London, E. D., Olmstead, R. E., Farahi, J., Scheibal, D., Jou, J., Allen, V., Tiongson, E., Chefer, S. I., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.907 · Cited by 367
Nicotine Medications for Smoking Cessation
Henningfield, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331807 · Cited by 352
Cigarette smoking and diabetes
Eliasson, B. (2003) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2003.00103 · Cited by 310
Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement
Donny, E. C., Chaudhri, N., Caggiula, A. R., Evans-Martin, F. F., Booth, S., Gharib, M. A., Clements, L. A., & Sved, A. F. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1473-3 · Cited by 304
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation
Lerman, C. E., Tyndale, R. F., Patterson, F., Wileyto, E. P., Shields, P. G., PINTO, A., & Benowitz, N. L. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.02.006 · Cited by 280
Self-citation
Nicotinic acetylcholine receptors as targets for antidepressants
Shytle, R. D., Silver, A. A., Lukas, R. J., Newman, M. B., Sheehan, D. V., & Sanberg, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001035 · Cited by 279
Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence*
Malaiyandi, V., Sellers, E. M., & Tyndale, R. F. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.10.011 · Cited by 269
The neurobiology of tobacco dependence: A preclinical perspective on the role of the dopamine projections to the nucleus
Balfour, D. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200412331324965 · Cited by 251 · cited 3×
“Another theory is that conditioned smoking cues maintain smoking behavior during periods of saturation and desensitization of brain nAChRs (23, 24).”
Background
Major depression following smoking cessation
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.2.263 · Cited by 250
CRF–CRF 1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats
George, O., Ghozland, S., Azar, M. R., Cottone, P., Zorrilla, E. P., Parsons, L. H., O'Dell, L. E., Richardson, H. N., & Koob, G. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707585104 · Cited by 245
Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study
Luo, J., Ye, W., Zendehdel, K., Adami, J., Adami, H.-O., Boffetta, P., & Nyrén, O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60678-3 · Cited by 242
Cigarette smoking and diabetes
Eliasson, B. (2003) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(03)80004-x · Cited by 228
The Selective α7 Nicotinic Acetylcholine Receptor Agonist PNU-282987 [N-[(3 R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide Hydrochloride] Enhances GABAergic Synaptic Activity in Brain Slices and Restores Auditory Gating Deficits in Anesthetized Rats
Hajós, M., Hurst, R. S., Hoffmann, W. E., Krause, M., Wall, T. M., Higdon, N. R., & Groppi, V. E. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076968 · Cited by 225
Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat
Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1445-7 · Cited by 223
Dissociating nicotine and nonnicotine components of cigarette smoking
Rose, J. E., Behm, F. M., Westman, E. C., & Johnson, M. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00301-4 · Cited by 222
CYP2A6 genotype and the metabolism and disposition kinetics of nicotine
BENOWITZ, N., SWAN, G., JACOBIII, P., LESSOVSCHLAGGAR, C., & TYNDALE, R. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.08.011 · Cited by 217
Self-citation
Schizophrenia and the α7 Nicotinic Acetylcholine Receptor
Martin, L. F., & Freedman, R. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78008-4 · Cited by 213
Slower Metabolism and Reduced Intake of Nicotine From Cigarette Smoking in Chinese-Americans
BENOWITZ, N., Pérez‐Stable, E. J., Herrera, B., & Jacob, P. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.2.108 · Cited by 211
Self-citation
Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers
Fujieda, M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh258 · Cited by 209
Functional brain imaging of tobacco use and dependence
BRODY, A. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.04.012 · Cited by 207
The Nicotinic Acetylcholine Receptor Subunit α5 Mediates Short-Term Effects of Nicotine in Vivo
Salas, R., Orr‐Urtreger, A., Broide, R. S., Beaudet, A. L., Paylor, R. E., & Biasi, M. D. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1059 · Cited by 200
Safety and immunogenicity of a nicotine conjugate vaccine in current smokers
HATSUKAMI, D., RENNARD, S., JORENBY, D., FIORE, M., KOOPMEINERS, J., DEVOS, A., HORWITH, G., & PENTEL, P. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.08.007 · Cited by 194
AR-R 17779, an α7 nicotinic agonist, improves learning and memory in rats
Levin, E. D., Bettegowda, C., Blosser, J. C., & Gordon, J. C. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199911000-00014 · Cited by 193
Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo-controlled Trial of Bupropion
Patterson, F., Schnoll, R. A., Wileyto, E. P., Pinto, A. V., Epstein, L., Shields, P. G., Hawk, L. W., Tyndale, R. F., Benowitz, N. L., & Lerman, C. E. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.57 · Cited by 181
Self-citation
Desensitized nicotinic receptors in brain
Wang, H., & Sun, X. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.09.003 · Cited by 175
Adverse pregnancy outcomes in snuff users
England, L. J., Levine, R. J., Mills, J. L., Klebanoff, M. A., Yu, K. F., & Cnattingius, S. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00661-6 · Cited by 174
Monoamine oxidase and tobacco dependence
Lewis, A., Miller, J. H., & Lea, R. A. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.05.019 · Cited by 159
Smoking and endothelial function
Puranik, R., & Celermajer, D. S. (2003) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2003.ypcad13 · Cited by 157
Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs
Uhl, G. R., Liu, Q., Drgon, T., Johnson, C., Walther, D. M., & Rose, J. E. (2007) · BMC Genetics · doi:10.1186/1471-2156-8-10 · Cited by 156
Nicotine and angiogenesis: a new paradigm for tobacco‐related diseases
Cooke, J. P., & Bitterman, H. (2004) · Annals of Medicine · doi:10.1080/07853890310017576 · Cited by 136
Perinatal exposure to nicotine causes deficits associated with a loss of nicotinic receptor function
Cohen, G., Roux, J.-C., Grailhe, R., Malcolm, G., Changeux, J.-P., & Lagercrantz, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409782102 · Cited by 134
CYP2B6 Genotype Alters Abstinence Rates in a Bupropion Smoking Cessation Trial
Lee, A. M., Jepson, C., Hoffmann, E. B., Epstein, L. H., Hawk, L. W., Lerman, C. E., & Tyndale, R. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.005 · Cited by 131
Role of nicotine dose and sensory cues in the regulation of smoke intake
Rose, J. E., Behm, F. M., & Levin, E. D. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90021-k · Cited by 125
Overview of the pharmacogenomics of cigarette smoking
Ho, M., & Tyndale, R. F. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500436 · Cited by 117
Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation
Cahill, K., & USSHER, M. H. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005353.pub2 · Cited by 114
Individualizing Nicotine Replacement Therapy for the Treatment of Tobacco Dependence: A Randomized Trial
Lerman, C., Kaufmann, V., Rukstalis, M., Patterson, F., Perkins, K., Audrain-McGovern, J., & Benowitz, N. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-6-200403160-00009 · Cited by 110
Self-citation
Nicotine and apoptosis
Zeidler, R., Albermann, K., & Lang, S. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0102-8 · Cited by 107
Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems
Kenny, P. J., & Markou, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4785-04.2005 · Cited by 107
Repeated nicotine exposure enhances responding with conditioned reinforcement
Olausson, P., Jentsch, J. D., & Taylor, J. R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1702-9 · Cited by 101
Genetics of nicotine dependence and pharmacotherapy
Lessov‐Schlaggar, C. N., Pergadia, M. L., Khroyan, T. V., & Swan, G. E. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.018 · Cited by 97
Smoking reduction treatment with 4-mg nicotine gum: A double-blind, randomized, placebo-controlled study
Batra, A., Klingler, K., Landfeldt, B., Friederich, H., Westin, Å., & Danielsson, T. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.08.019 · Cited by 94
Genetic analyses of DSM-IV nicotine withdrawal in adult twins
PERGADIA, M. L., HEATH, A. C., MARTIN, N. G., & MADDEN, P. A. F. (2006) · Psychological Medicine · doi:10.1017/s0033291706007495 · Cited by 89
Clinical significance of tobacco withdrawal
Hughes, J. R. (2006) · Nicotine & Tobacco Research · doi:10.1080/14622200500494856 · Cited by 80
Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell
Paterson, N. E., Balfour, D. J. K., & Markou, A. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05546.x · Cited by 80
Tranylcypromine enhancement of nicotine self-administration
Villégier, A., Lotfipour, S., McQuown, S. C., Belluzzi, J. D., & Leslie, F. M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.02.001 · Cited by 71
Non-Nicotinic Therapies for Smoking Cessation
Siu, E. C. K., & Tyndale, R. F. (2007) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105354 · Cited by 69
Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco
Henley, S. J., Connell, C. J., Richter, P., Husten, C. G., Pechacek, T. F., Calle, E. E., & Thun, M. J. (2007) · Tobacco Control · doi:10.1136/tc.2006.018069 · Cited by 66
The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking
Wennberg, P., Eliasson, M., Hallmans, G., Johansson, L., Boman, K., & Jansson, J. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01813.x · Cited by 64
ROLE OF HUMAN CYTOCHROME P450 (CYP) IN THE METABOLIC ACTIVATION OF NITROSAMINE DERIVATIVES: APPLICATION OF GENETICALLY ENGINEEREDSALMONELLAEXPRESSING HUMAN CYP
Kamataki, T., Fujita, K., Nakayama, K., Yamazaki, Y., Miyamoto, M., & Ariyoshi, N. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120005668 · Cited by 58
Cardiovascular responses to microinjections of nicotine into the caudal ventrolateral medulla of the rat
Aberger, K., Chitravanshi, V. C., & Sapru, H. N. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03250-9 · Cited by 40
Desensitized nicotinic receptors in brain.
Wang, & Sun (2006) · 中国生物学文摘 · Cited by 15
NICOTINE EFFECTS ON WORKING MEMORY
Levin, E. D. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199908001-00145 · Cited by 9

Research works printed but not linked: 4

Cent. Dis. Control Prev, 2002, MMWR, 51, 637
Colton CW, 2006, Prev. Chronic Dis., 3, A42
Slemmer JE, 2000, J. Pharmacol. Exp. Ther., 295, 321
Cahill K, 2007, Cochrane Database Syst. Rev., 2007, CD005353

Sorted by citations

The Methylation Effect in Medicinal Chemistry
Barreiro, E. J., Kümmerle, A. E., & Fraga, C. A. M. (2011) · Chemical Reviews · doi:10.1021/cr200060g · Cited by 1,032
Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence
Leventhal, A. M., Strong, D. R., Kirkpatrick, M. G., Unger, J. B., Sussman, S., Riggs, N. R., Stone, M. D., Khoddam, R., Samet, J. M., & Audrain-McGovern, J. (2015) · JAMA · doi:10.1001/jama.2015.8950 · Cited by 913
Plants Secondary Metabolites: The Key Drivers of the Pharmacological Actions of Medicinal Plants
Hussein, R. A., & El‐Anssary, A. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.76139 · Cited by 494
Lung carcinogenesis by tobacco smoke
Hecht, S. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27816 · Cited by 502
Cognitive Effects of Nicotine
Sofouglu, M., Herman, A. I., Robinson, C. D., & Waters, A. J. (2014) · Lincoln (University of Nebraska) · Cited by 417

See all 979

Authors: Benowitz, N. L.
Affiliations: San Francisco General Hospital (US)
Corresponding author: Benowitz, Neal L.
ORCID: Benowitz, Neal L.
Venue: Annual Review of Pharmacology and Toxicology
Publisher: Annual Reviews
Published: 2009-02-01
Volume: 49
Issue: 1
Pages: 57-71
ISSN: 0362-1642 (ISSN-L)
1545-4304
DOI: 10.1146/annurev.pharmtox.48.113006.094742
PMC: PMC2946180
OpenAlex: W2137599927
Cited by: 979
References: 90
Citations by year: 2026: 75 · 2025: 89 · 2024: 91 · 2023: 89 · 2022: 72 · 2021: 70 · 2020: 60 · 2019: 56 · 2018: 42 · 2017: 55 · 2016: 37 · 2015: 42 · 2014: 43 · 2013: 39 · 2012: 35
FWCI: 2.95
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: The Annual Review of Pharmacology and Toxicology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Public Health Service
National Institute on Drug Abuse (DA20830, DA02277, R01DA002277, U01DA020830, R37DA002277)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords: nicotine, tobacco dependence, nicotine dependence, nicotinic acetylcholine receptors, nicotine withdrawal, dopamine release, glutamate release, GABA release, corticotropin-releasing factor, genetic susceptibility, CYP2A6, nicotine metabolism, lung cancer risk, smoking cessation, mental illness, substance abuse, nicotine replacement therapy, bupropion, varenicline, partial agonists
MeSH terms: Varenicline, Animals, Benzazepines, Nonprescription Drugs, Ganglionic Stimulants, Humans, Nicotine, Quinoxalines, Smoking, Tobacco Use Disorder, Bupropion, Behavior, Addictive, Nicotinic Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and Therapeutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks